Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 19, 2021 07:30 ET | Source: Humacyte, Inc.

Humacyte Highlights Robust Expanded Access Program and Patient Testimonial for Human Acellular Vessels

In addition to the Company’s eight ongoing clinical trials, HAVs have been used in 13 expanded access cases for emergent life- and limb-saving vascular surgeries at seven hospitals across the...
August 17, 2021 07:30 ET | Source: Humacyte, Inc.

Humacyte Announces Addition of Chief Commercial Officer and Integration of Commercial-Scale Manufacturing into Clinical Trial Programs

Appoints proven commercial leader B.J. Scheessele as Chief Commercial OfficerIn-house Durham, N.C. facility is operational and supplying clinical trial material produced in commercial-scale...
August 13, 2021 07:30 ET | Source: Humacyte, Inc.

Alpha Healthcare and Humacyte Announce Nominees for Election to Post-Merger Public Company Board of Directors

Nominees bring depth and diversity of scientific, commercial and financial experience to Board NEW YORK and DURHAM, N.C., Aug. 13, 2021 (GLOBE NEWSWIRE) -- Alpha Healthcare Acquisition Corp....
August 11, 2021 07:30 ET | Source: Humacyte, Inc.

Humacyte Announces Publication of In Vivo Data on Biovascular Pancreas Transplantation for the Treatment of Type 1 Diabetes

Data demonstrate biovascular pancreas may have the potential to provide an effective and safe method for pancreatic islet cell transplantation for the treatment of type 1 diabetes Data published in...
August 04, 2021 16:53 ET | Source: Humacyte, Inc.

Alpha Healthcare Acquisition Corp. Sets August 24, 2021, for Special Shareholder Meeting to Vote on Humacyte Business Combination

Special shareholder meeting to approve, among other items, the proposed business combination with Humacyte, Inc. to be held August 24, 2021, at 10:00 a.m. EDTShareholders as of the close of business...
July 22, 2021 07:30 ET | Source: Humacyte, Inc.

Humacyte Presents Potential of Functional Lung Engineering at Janelia R3 – Replace, Repair, Regenerate Planning Workshop

DURHAM, N.C., July 22, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale,...
June 11, 2021 15:03 ET | Source: Humacyte, Inc.

UPDATE -- Humacyte Expands Strategic Global Partnership with Fresenius Medical Care

Partnership expanded to include vascular trauma repair outside of the United States.Fresenius Medical Care is a leading participant in fully committed PIPE financing transaction. DURHAM, N.C., June ...
June 10, 2021 07:30 ET | Source: Humacyte, Inc.

Humacyte to Participate in Fireside Chat at Cowen 6th Annual FutureHealth Conference

DURHAM, N.C., June 10, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale,...
June 08, 2021 07:30 ET | Source: Humacyte, Inc.

Humacyte Presents In Vivo Data on Biovascular Pancreas Transplantation for Type 1 Diabetes Treatment

Laboratory and preclinical models demonstrate biovascular pancreas platform technology may provide method to transplant islet cells that produce insulin in Type 1 diabetes patientsData presented at...
June 04, 2021 07:30 ET | Source: Humacyte, Inc.

Humacyte to Provide Investor Update on June 7

DURHAM, N.C., June 04, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale,...